Saul J. Karpen

16.5k total citations · 6 hit papers
172 papers, 9.1k citations indexed

About

Saul J. Karpen is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Saul J. Karpen has authored 172 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Surgery, 67 papers in Oncology and 50 papers in Epidemiology. Recurrent topics in Saul J. Karpen's work include Pediatric Hepatobiliary Diseases and Treatments (69 papers), Drug Transport and Resistance Mechanisms (58 papers) and Liver Disease Diagnosis and Treatment (40 papers). Saul J. Karpen is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (69 papers), Drug Transport and Resistance Mechanisms (58 papers) and Liver Disease Diagnosis and Treatment (40 papers). Saul J. Karpen collaborates with scholars based in United States, Canada and United Kingdom. Saul J. Karpen's co-authors include Paul A. Dawson, Marco Arrese, Astrid Kosters, Tracy L. Zimmerman, Michael Trauner, Barbara O. McElhanon, Courtney McCracken, William G. Sharp, Miriam B. Vos and Jean A. Welsh and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Saul J. Karpen

170 papers receiving 8.9k citations

Hit Papers

Gastrointestinal Symptoms in Autism Spectrum Disorder: A ... 2012 2026 2016 2021 2014 2016 2014 2012 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saul J. Karpen United States 53 4.0k 2.8k 2.7k 1.9k 1.9k 172 9.1k
Henkjan J. Verkade Netherlands 48 3.3k 0.8× 1.8k 0.6× 1.7k 0.6× 1.8k 1.0× 1.2k 0.6× 311 8.1k
Antonio Moschetta Italy 56 5.0k 1.2× 3.9k 1.4× 4.9k 1.8× 5.4k 2.9× 1.3k 0.7× 202 13.8k
Giuseppe Palasciano Italy 39 2.2k 0.6× 1.5k 0.5× 1.0k 0.4× 1.2k 0.7× 719 0.4× 178 5.6k
Yukihiko Adachi Japan 42 946 0.2× 1.5k 0.5× 865 0.3× 1.4k 0.7× 871 0.5× 205 6.3k
Christopher J. Sinal Canada 43 2.0k 0.5× 3.1k 1.1× 3.2k 1.2× 2.6k 1.4× 428 0.2× 85 9.0k
Stergios A. Pοlyzos Greece 51 2.3k 0.6× 5.0k 1.8× 1.5k 0.6× 2.4k 1.3× 1.1k 0.6× 301 10.9k
Guido N.J. Tytgat Netherlands 54 6.8k 1.7× 1.6k 0.6× 2.2k 0.8× 1.6k 0.8× 329 0.2× 199 11.3k
Julian R.F. Walters United Kingdom 44 2.4k 0.6× 1.5k 0.5× 948 0.3× 1.3k 0.7× 414 0.2× 157 6.2k
Jan B.�M.�J. Jansen Netherlands 52 4.8k 1.2× 1.5k 0.5× 2.3k 0.9× 1.5k 0.8× 188 0.1× 349 10.6k
Goro Kajiyama Japan 53 4.1k 1.0× 904 0.3× 2.1k 0.8× 2.0k 1.1× 365 0.2× 434 10.0k

Countries citing papers authored by Saul J. Karpen

Since Specialization
Citations

This map shows the geographic impact of Saul J. Karpen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saul J. Karpen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saul J. Karpen more than expected).

Fields of papers citing papers by Saul J. Karpen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saul J. Karpen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saul J. Karpen. The network helps show where Saul J. Karpen may publish in the future.

Co-authorship network of co-authors of Saul J. Karpen

This figure shows the co-authorship network connecting the top 25 collaborators of Saul J. Karpen. A scholar is included among the top collaborators of Saul J. Karpen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saul J. Karpen. Saul J. Karpen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghallab, Ahmed, Mattias Mandorfer, Guido Stirnimann, et al.. (2025). Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors. Journal of Hepatology. 83(5). 1204–1217. 3 indexed citations
3.
Fay, Meredith E., Ashley Bennett, Kimberly Pachura, et al.. (2024). BiliQML: a supervised machine-learning model to quantify biliary forms from digitized whole slide liver histopathological images. American Journal of Physiology-Gastrointestinal and Liver Physiology. 327(1). G1–G15. 2 indexed citations
4.
Shen, Luyao, et al.. (2023). Opportunities and considerations for studying liver disease with microphysiological systems on a chip. Lab on a Chip. 23(13). 2877–2898. 8 indexed citations
5.
Karpen, Saul J., et al.. (2023). Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy. Seminars in Liver Disease. 43(3). 323–335. 7 indexed citations
6.
Bennett, Ashley, Sudarshan Malla, Caroline Klindt, et al.. (2023). Liver-restricted deletion of the biliary atresia candidate gene Pkd1l1 causes bile duct dysmorphogenesis and ciliopathy. Hepatology. 77(4). 1274–1286. 18 indexed citations
7.
Wilkins, Benjamin J., et al.. (2023). Loss of zebrafish pkd1l1 causes biliary defects that have implications for biliary atresia splenic malformation. Disease Models & Mechanisms. 16(10). 4 indexed citations
8.
Karpen, Saul J.. (2018). Novel Bile Acid Therapies for Liver Disease.. PubMed Central. 14(2). 117–119. 2 indexed citations
9.
Desai, Moreshwar S., Hernán Vásquez, Heinrich Taegtmeyer, et al.. (2016). Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart. Hepatology. 65(1). 189–201. 104 indexed citations
10.
Kamath, Binita M., Zhen Chen, René Romero, et al.. (2015). Quality of Life and Its Determinants in a Multicenter Cohort of Children with Alagille Syndrome. The Journal of Pediatrics. 167(2). 390–396.e3. 18 indexed citations
11.
Karpen, Saul J., et al.. (2015). Genetic Contributors and Modifiers of Biliary Atresia. Digestive Diseases. 33(3). 408–414. 32 indexed citations
12.
McElhanon, Barbara O., Courtney McCracken, Saul J. Karpen, & William G. Sharp. (2014). Gastrointestinal Symptoms in Autism Spectrum Disorder: A Meta-analysis. PEDIATRICS. 133(5). 872–883. 564 indexed citations breakdown →
13.
Desai, Moreshwar S., et al.. (2014). Abstract 18219: TGR5 - a Novel Membrane Receptor for Bile Acids Regulates Myocardial Response to Exercise, Catecholamine and Pressure Overload Induced Stress. Circulation. 130. 2 indexed citations
14.
15.
Shneider, Benjamin L., John Magee, Jorge A. Bezerra, et al.. (2012). Efficacy of Fat-Soluble Vitamin Supplementation in Infants With Biliary Atresia. PEDIATRICS. 130(3). e607–e614. 66 indexed citations
16.
Harpavat, Sanjiv, Milton J. Finegold, & Saul J. Karpen. (2011). Patients With Biliary Atresia Have Elevated Direct/Conjugated Bilirubin Levels Shortly After Birth. PEDIATRICS. 128(6). e1428–e1433. 127 indexed citations
17.
Chopra, Atul R., Jean‐François Louet, Pradip Saha, et al.. (2008). Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease. Science. 322(5906). 1395–1399. 133 indexed citations
18.
Lee, Timothy C., Neal R. Barshes, Christine A. O’Mahony, et al.. (2006). Resolution of medically resistant hypothyroidism after liver transplantation for hepatic hemangioendothelioma. Journal of Pediatric Surgery. 41(10). 1783–1785. 18 indexed citations
19.
Chang, I‐Fen, et al.. (2004). P0096 PP POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS TREATED WITH ANTI‐CD20 MONOCLONAL ANTIBODY: A LONG‐TERM OUTCOME STUDY. Journal of Pediatric Gastroenterology and Nutrition. 39(S1). 1 indexed citations
20.
Denson, Lee A., et al.. (2000). Interleukin-1β Suppresses Retinoid Transactivation of Two Hepatic Transporter Genes Involved in Bile Formation. Journal of Biological Chemistry. 275(12). 8835–8843. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026